Coxib-inhibition of Duodenal Polyp Growth in FAP
Ontology highlight
ABSTRACT: Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
DISEASE(S): Duodenal Polyposis,Colorectal Neoplasms,Nasopharyngeal Neoplasms
PROVIDER: 2068021 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA